Filing Details
- Accession Number:
- 0001209191-19-020139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-18 20:02:48
- Reporting Period:
- 2019-03-14
- Accepted Time:
- 2019-03-18 20:02:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1720077 | S Ratan Borkar | 12544 High Bluff Drive Suite 200 San Diego CA 92130 | Svp, Intl Comm Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-14 | 5,376 | $23.41 | 21,272 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-14 | 5,376 | $15.40 | 26,648 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-03-14 | 3,797 | $21.08 | 30,445 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-14 | 14,549 | $68.00 | 16,193 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-03-14 | 5,376 | $0.00 | 5,376 | $23.41 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-03-14 | 5,376 | $0.00 | 5,376 | $15.40 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-03-14 | 3,797 | $0.00 | 3,797 | $21.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,376 | 2025-02-05 | No | 4 | M | Direct | |
| 16,130 | 2026-02-10 | No | 4 | M | Direct | |
| 3,796 | 2027-02-15 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $68.00 per share, with a range of $68.00 to 68.00. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The amount of securities beneficially owned following this transaction include an additional 297 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
- 10,754 shares vested on 2/5/2017; 5,376 shares vested on 2/5/2018; and 5,376 shares vested on 2/5/2019.
- 10,754 shares vested on 2/10/2018; 5,376 shares vested on 2/10/2019; and 5,376 shares will vest on 2/10/2020.
- 3,797 shares vested on 2/15/2019; 1,898 shares will vest on 2/15/2020; and 1,898 shares will vest on 2/15/2021.
Billionaire Hedge Funds
